Your browser doesn't support javascript.
loading
Discontinuation of tyrosine kinase inhibitors in CML patients in real-world clinical practice at a single institution.
Cerveira, Nuno; Loureiro, Bruno; Bizarro, Susana; Correia, Cecília; Torres, Lurdes; Lisboa, Susana; Vieira, Joana; Santos, Rui; Pereira, Dulcineia; Moreira, Cláudia; Chacim, Sérgio; Domingues, Nélson; Espírito-Santo, Ana; Oliveira, Isabel; Moreira, Ilídia; Viterbo, Luísa; Martins, Ângelo; Teixeira, Manuel R; Mariz, José M.
Afiliação
  • Cerveira N; Department of Genetics, Portuguese Oncology Institute, Porto, Portugal. nscerveira@gmail.com.
  • Loureiro B; Department of Onco-Haematology, Portuguese Oncology Institute, Porto, Portugal.
  • Bizarro S; Department of Genetics, Portuguese Oncology Institute, Porto, Portugal.
  • Correia C; Department of Genetics, Portuguese Oncology Institute, Porto, Portugal.
  • Torres L; Department of Genetics, Portuguese Oncology Institute, Porto, Portugal.
  • Lisboa S; Department of Genetics, Portuguese Oncology Institute, Porto, Portugal.
  • Vieira J; Department of Genetics, Portuguese Oncology Institute, Porto, Portugal.
  • Santos R; Department of Genetics, Portuguese Oncology Institute, Porto, Portugal.
  • Pereira D; Department of Onco-Haematology, Portuguese Oncology Institute, Porto, Portugal.
  • Moreira C; Department of Onco-Haematology, Portuguese Oncology Institute, Porto, Portugal.
  • Chacim S; Department of Onco-Haematology, Portuguese Oncology Institute, Porto, Portugal.
  • Domingues N; Department of Onco-Haematology, Portuguese Oncology Institute, Porto, Portugal.
  • Espírito-Santo A; Department of Onco-Haematology, Portuguese Oncology Institute, Porto, Portugal.
  • Oliveira I; Department of Onco-Haematology, Portuguese Oncology Institute, Porto, Portugal.
  • Moreira I; Department of Onco-Haematology, Portuguese Oncology Institute, Porto, Portugal.
  • Viterbo L; Department of Onco-Haematology, Portuguese Oncology Institute, Porto, Portugal.
  • Martins Â; Department of Onco-Haematology, Portuguese Oncology Institute, Porto, Portugal.
  • Teixeira MR; Department of Genetics, Portuguese Oncology Institute, Porto, Portugal.
  • Mariz JM; Institute of Biomedical Sciences (ICBAS), University of Porto, Porto, Portugal.
BMC Cancer ; 18(1): 1245, 2018 Dec 12.
Article em En | MEDLINE | ID: mdl-30541488
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Suspensão de Tratamento / Inibidores de Proteínas Quinases Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Suspensão de Tratamento / Inibidores de Proteínas Quinases Idioma: En Ano de publicação: 2018 Tipo de documento: Article